U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Desert Rose Manufacturing, Inc - Close Out Letter 7/13/16
  1. Compliance Actions and Activities

CLOSEOUT LETTER

Desert Rose Manufacturing, Inc


Desert Rose Manufacturing, Inc

  

Department of Health and Human Services' logoDepartment of Health and Human Services

Southwest Region
 Food and Drug Administration
Denver District Office
Bldg. 20-Denver Federal Center
P.O. Box 25087
6th Avenue & Kipling Street
Denver, Colorado 80225-0087
Telephone: 303-236-3000
FAX:          303-236-3551

July 13, 2016


Mr. Gene S. (Sylvester) Eagle-Oden, Co-Owner
Mrs. Gene S. (Susan) Eagle-Oden, Co-Owner
Desert Rose Manufacturing, Inc.
1810 Washington Street
Anthony, NM 88021


Dear Mr. and Mrs. Eagle-Oden:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, DEN-13-09-WL, dated March 01, 2013. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,

/S/

LaTonya M. Mitchell
Denver District Director


LMM/cap